Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market-2027

SEATTLE - June 1, 2021 - PRLog -- Surgical adhesion barriers are implants or solutions used to prevent internal scarring due to sticking of tissues or internal organs to each other after surgery or during healing process. Majority of adhesion barrier products are in nascent stage of product life cycle and thus market is evolving gradually. Adhesion barrier products considered in the report include film-based, solution-based, and gel-based adhesion barriers.

The global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market is estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$ 7,346.7 Mn by the end of 2027

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Drivers

High number of cardiovascular procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3721

Orthopedic Surgeries segment held dominant position in the global surgical hemostats, internal tissue sealants and adhesion barriers market in 2019, accounting for 27.5% share in terms of value, followed by Cardiovascular Surgeries and Neurological Surgeries, respectively. Highest prevalence of bone related disorders has been reported in North America. For instance, according to the statistics by WHO, in U.S., by the year 2040, around 78.4 million adults aged 18 years and older will have doctor-diagnosed arthritis, compared to 54.4 million adults in 2013-2015

Market Trends

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in June 2019, Ethicon, part of the Johnson & Johnson Medical Devices Companies, received a 510(k) clearance from the FDA for its Vistaseal applicators, which spray a biological sealant to stem moderate bleeding during open or laparoscopic surgical procedures.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/surgical-hemostats-internal-tissue-sealants-and-adhesion-barriers-market-3721

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Key Developments

December 2019: Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched VISTASEAL Fibrin Sealant (Human) to help surgeons manage bleeding during surgery

December 2018: Baxter International Inc. launched its disposable curved applicator that is designed to enhance the delivery of its Floseal Hemostatic Matrix product line

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3721